Year-To-date Performace: ----> CZO up 27.87% <----
S&P Biotech ETF down 26.4%.
TSX-Venture down 31.42%.
NASDAQ down 22.9%.
Russell 2000 down 16%.
S&P 500 down 15%.
Since Gilles became President and CEO CZO is up 721%.
That's an approximate 22% annual compound return.